Compare VKTX & ESAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VKTX | ESAB |
|---|---|---|
| Founded | 2012 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.4B |
| IPO Year | 2014 | 2022 |
| Metric | VKTX | ESAB |
|---|---|---|
| Price | $27.05 | $69.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 21 | 11 |
| Target Price | $95.32 | ★ $119.73 |
| AVG Volume (30 Days) | ★ 4.8M | 1.2M |
| Earning Date | 10-28-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 0.65% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.27 |
| Revenue | N/A | ★ $2,842,555,000.00 |
| Revenue This Year | N/A | $7.52 |
| Revenue Next Year | N/A | $9.14 |
| P/E Ratio | ★ N/A | $58.14 |
| Revenue Growth | N/A | ★ 3.71 |
| 52 Week Low | $23.82 | $62.74 |
| 52 Week High | $43.15 | $137.42 |
| Indicator | VKTX | ESAB |
|---|---|---|
| Relative Strength Index (RSI) | 46.50 | 51.79 |
| Support Level | $26.47 | $63.79 |
| Resistance Level | $34.00 | $72.65 |
| Average True Range (ATR) | 1.53 | 2.60 |
| MACD | 0.27 | 0.94 |
| Stochastic Oscillator | 70.21 | 55.58 |
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.8 billion in revenue in 2025.